Evaluation of the Safety, Tolerability, and Pharmacokinetics of Gammaplex® 10% Versus Gammaplex® 5% in Subjects with Primary Immunodeficiency - Wasserman, Richard L.; Melamed, Isaac R.; Stein, Mark R.; Jolles, Stephen; Norton, Miranda; Moy, James N. (Journal of clinical immunology, 2017)
Keywords: Adolescent; Adult; Biomedical and Life Sciences; Biomedicine; Child; Child, Preschool; Female; Humans; Immunoglobulin G - blood; Immunoglobulins, Intravenous - administration & dosage; Immunoglobulins, Intravenous - adverse effects; Immunoglobulins, Intravenous - pharmacokinetics; Immunoglobulins, Intravenous - therapeutic use; Immunologic Deficiency Syndromes - blood; Immunologic Deficiency Syndromes - diagnosis; Immunologic Deficiency Syndromes - drug therapy; Immunology; Infectious Diseases; Internal Medicine; Male; Medical Microbiology; Middle Aged; Original; Original Article; Treatment Outcome; Young Adult; Gammaplex; Primary immunodeficiency disease (PID); 5; intravenous immunoglobulin (IVIG); 10; Gammaplex® 5; Gammaplex® 10